Browsing Centre for Immunobiology by Subject "5.1 Pharmaceuticals"
Now showing items 1-5 of 5
-
P570 Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN
(Oxford University Press (OUP), 2024-01-24)